Press release
Hyperopia Market on Track for Major Expansion by 2034, According to DelveInsight | Vyluma, Center For Excellence In Eye Care, Technolas Perfect Vision GmbH
DelveInsight's "Hyperopia Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Hyperopia, historical and forecasted epidemiology as well as the Hyperopia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Hyperopia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Hyperopia Market Forecast [https://www.delveinsight.com/sample-request/hyperopia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Hyperopia Market Report:
*
The Hyperopia market size was valued approximately ~USD 3200 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
*
In January 2025, ZEISS Medical Technology announced that the MEL Registered 90 received FDA approval for myopia, hyperopia, and mixed astigmatism. The excimer laser integrates into the Corneal Refractive Workflow, providing U.S. surgeons with a fast, reliable, and streamlined surgery experience, complementing the VISUMAX Registered 800 with SMILE Registered pro to enhance refractive practices and improve patient outcomes.
*
Among the 7MM, the United States accounted for the highest market size i.e. approximately USD 1800 million in 2023, and is expected to grow during the forecast.
*
In the US, the overall prevalent cases of hyperopia surpassed 16 million in 2023, with projections indicating further growth in the forecast period.
*
According to the analysis, hyperopia was observed to be more prevalent among individuals aged 60-69 years in the US, constituting approximately 25% of the total cases.
*
At present, there are no authorized treatments available for hyperopia. Nevertheless, Vyluma is progressing with the development of a drug named NVK-033 intended for hyperopia treatment, currently in the clinical proof-of-principle phase.
*
Key Hyperopia Companies: Vyluma, Center For Excellence In Eye Care, Technolas Perfect Vision GmbH, and others
*
Key Hyperopia Therapies: NVK-033, ketorolac (Acular LS), Supracor, and others
*
The Hyperopia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Hyperopia pipeline products will significantly revolutionize the Hyperopia market dynamics.
Hyperopia Overview
Hyperopia, commonly known as farsightedness, is a refractive error of the eye where distant objects can be seen more clearly than nearby objects. This occurs when the eyeball is shorter than normal or when the cornea has too little curvature.
Get a Free sample for the Hyperopia Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/hyperopia-market [https://www.delveinsight.com/report-store/hyperopia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Hyperopia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Hyperopia Epidemiology Segmentation:
The Hyperopia market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
*
Total Prevalence of Hyperopia
*
Prevalent Cases of Hyperopia by severity
*
Gender-specific Prevalence of Hyperopia
*
Diagnosed Cases of Episodic and Chronic Hyperopia
Download the report to understand which factors are driving Hyperopia epidemiology trends @ Hyperopia Epidemiology Forecast [https://www.delveinsight.com/sample-request/hyperopia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Hyperopia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Hyperopia market or expected to get launched during the study period. The analysis covers Hyperopia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Hyperopia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Hyperopia Therapies and Key Companies
*
NVK-033: Vyluma
*
ketorolac (Acular LS): Center For Excellence In Eye Care
*
Supracor: Technolas Perfect Vision GmbH
Discover more about therapies set to grab major Hyperopia market share @ Hyperopia Treatment Landscape [https://www.delveinsight.com/sample-request/hyperopia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Scope of the Hyperopia Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Hyperopia Companies: Vyluma, Center For Excellence In Eye Care, Technolas Perfect Vision GmbH, and others
*
Key Hyperopia Therapies: NVK-033, ketorolac (Acular LS), Supracor, and others
*
Hyperopia Therapeutic Assessment: Hyperopia current marketed and Hyperopia emerging therapies
*
Hyperopia Market Dynamics: Hyperopia market drivers and Hyperopia market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Hyperopia Unmet Needs, KOL's views, Analyst's views, Hyperopia Market Access and Reimbursement
To know more about Hyperopia companies working in the treatment market, visit @ Hyperopia Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/hyperopia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Hyperopia Market Report Introduction
2. Executive Summary for Hyperopia
3. SWOT analysis of Hyperopia
4. Hyperopia Patient Share (%) Overview at a Glance
5. Hyperopia Market Overview at a Glance
6. Hyperopia Disease Background and Overview
7. Hyperopia Epidemiology and Patient Population
8. Country-Specific Patient Population of Hyperopia
9. Hyperopia Current Treatment and Medical Practices
10. Hyperopia Unmet Needs
11. Hyperopia Emerging Therapies
12. Hyperopia Market Outlook
13. Country-Wise Hyperopia Market Analysis (2020-2034)
14. Hyperopia Market Access and Reimbursement of Therapies
15. Hyperopia Market Drivers
16. Hyperopia Market Barriers
17. Hyperopia Appendix
18. Hyperopia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=hyperopia-market-on-track-for-major-expansion-by-2034-according-to-delveinsight-vyluma-center-for-excellence-in-eye-care-technolas-perfect-vision-gmbh]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hyperopia Market on Track for Major Expansion by 2034, According to DelveInsight | Vyluma, Center For Excellence In Eye Care, Technolas Perfect Vision GmbH here
News-ID: 3832560 • Views: …
More Releases from ABNewswire
Myelofibrosis Market Outlook 2034 - Clinical Trials, Market Size, Medication, Pr …
Myelofibrosis Market Include Incyte Corporation, Keros Therapeutics, Karyopharm Therapeutics, Celgene Corporation, PharmaEssentia, Novartis, SecuraBio, Pharmaxis, Novartis Oncology, AstraZeneca, Cellenkos, Jacobio Pharmaceuticals, Ohmoncology, Geron Corporation, AbbVie, Sierra Oncology, Galecto Biotech, Actuate Therapeutics, Kartos Therapeutics, Menarini Group, Telios Pharma, Novartis Pharmaceuticals, NS Pharma, Celgene/Bristol-Myers Squibb, MorphoSys, Imago BioSciences, Roche, and others.
Myelofibrosis Market Summary
The Myelofibrosis market in the 7MM is set to grow significantly, rising from USD 2.6 billion in 2025 to USD…
Kid Connecticut Showcases Full Catalog of Authentic Innovation
Rising independent artist Kid Connecticut is making waves across streaming platforms with a catalog that blends sharp lyricism, genre-bending production, and unfiltered authenticity. With every release, Kid Connecticut has built a reputation as a creator who refuses to follow the industry blueprint. Instead, he offers listeners a body of work that reflects growth, resilience, and originality while capturing the reality of an artist evolving in real time.
From his earliest tracks…
Adeno-Associated Virus (AAV) Vectors in Gene Therapy Pipeline 2025: Innovations …
Adeno-Associated Virus (AAV) Vectors in Gene Therapy companies are Nanoscope Therapeutics, REGENXBIO, Astellas Gene Therapy, GeneCradle Therapeutics, Asklepios BioPharmaceutical, 4D Molecular Therapeutics, Adverum Biotechnologies, Rocket Pharmaceuticals, Innostellar Biotherapeutics, Passage Bio, Aspa Therapeutics, Solid Biosciences, Lantu Biopharma, Ascidian Therapeutics, Decibel Therapeutics, Sio Gene Therapies, and others.
As the use of Adeno-Associated Virus (AAV) vectors in gene therapy expands globally, there is increasing demand for safer and more effective treatment options, addressing conditions…
Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Market: …
The total market size of EGFR mNSCLC in the 7MM was ~USD 4,000 million in 2023.
Emerging EGFR-NSCLC therapies-such as TAGRISSO, GILOTRIF/GIOTRIF, TARCEVA, RYBREVANT, VIZIMPRO, IRESSA, PORTRAZZA, Aumolertinib, Zipalertinib, Furmonertinib, BDTX-1535, Dato-DXd, JIN-A02, NX-019, STX-721, and ORIC-11-are expected to drive market growth in the coming years.
DelveInsight's report, "Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) - Market Insights, Epidemiology, and Market Forecast-2034," provides a comprehensive analysis of EGFR-NSCLC, including historical…
More Releases for Hyperopia
Hyperopia Market is projected to reach USD 13.7 billion by 2034
Hyperopia, also known as farsightedness, is a common refractive error where distant objects are seen more clearly than near ones. It occurs due to the short axial length of the eye or abnormal corneal curvature, causing light to focus behind the retina. Symptoms include eye strain, blurred near vision, headaches, and difficulty with reading or prolonged near work.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72287
The growing global demand…
Global Hyperopia Treatment Market to Expand at 7.5% of CAGR Through 2025-2033, S …
Overview of the Market:
The Global Hyperopia Treatment Market has gained strong momentum in recent years, driven by rising cases of refractive errors, advancements in laser eye surgery, and growing awareness about early eye care. Hyperopia, commonly known as farsightedness, is a vision condition in which distant objects can be seen clearly, but nearby objects appear blurry. The increasing prevalence of hyperopia across both developed and emerging economies is creating significant…
Hyperopia Treatment Market Growth, Trends & Opportunities 2025-2033 | Top key pl …
Hyperopia Treatment Market, as analyzed in the study by DataM Intelligence, presents a detailed overview of the industry with in-depth insights, historical data, and key statistics. The report thoroughly examines market dynamics, competitive strategies, and major players, highlighting their product lines, pricing structures, financials, growth plans, and regional outreach.
The Global Hyperopia Treatment Market reached US$ 3,427.36 million in 2024 and is expected to reach US$ 6,651.86 million by 2033, growing…
Hyperopia Treatment Market: Innovative Solutions, Trends, and Growth Opportuniti …
The Global Hyperopia Treatment Market reached US$ 3,427.36 million in 2024 and is expected to reach US$ 6,651.86 million by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.
Hyperopia Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of…
Hyperopia Glasses Market - Latest Scenario on Innovation, Revolutionary Opportun …
The hyperopia glasses market is driven by factors such as the growing prevalence of hyperopia, the desire for corrective eyewear that combines functionality with fashion, and advancements in lens materials and coatings. As vision correction remains a priority for many individuals, the market is expected to continue evolving with innovations in eyewear technology and consumer preferences. Hyperopia, commonly known as farsightedness, is a vision condition where distant objects are seen…
Global Custom LASIK Surgery Market, By Procedure (Wavefront Guided, Wavefront Op …
Custom LASIK Surgery – Alternative to Eyewear
LASIK surgery is a highly effective method to correct vision and is especially useful in treatment of various refractive disorders such as myopia, hyperopia, and astigmatism. In the U.S. alone, over 34 million patients are suffering from myopia according to the American Academy of Ophthalmology 2016 estimates. Moreover, around 150 million people in the U.S. wear corrective eyeglasses. Custom LASIK surgery market revenue is…
